Streetbeat News

Stock Prices

AMZN

Amazon plans to upgrade its Alexa voice assistant with generative AI and introduce a monthly subscription fee. This move aims to make Alexa more competitive against advanced AI chatbots from companies like Google and OpenAI. The subscription will not be included in Amazon Prime. The overhaul comes amid internal pressure to justify the resources dedicated to Alexa and to keep up with AI advancements.

Portfolio Pulse from Benzinga Newsdesk

May 22, 2024 | 12:26 pm

AXP

BALL

QCOM

TDC

Insiders from Qualcomm, Ball Corporation, American Express, and Teradata have recently sold shares. Insider sales can indicate concerns about company prospects or overvaluation. Notable sales include Qualcomm's Neil Smit, Ball Corporation's Pedro Henrique Mariani, American Express's Raymond Joabar, and Teradata's Timothy C K Chou.

Portfolio Pulse from Avi Kapoor

May 22, 2024 | 12:20 pm

TNXP

Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) will deliver an oral presentation and present two posters at the ASCP Annual Meeting from May 28-31, 2024. The presentation will focus on Tonmya™ (TNX-102 SL) for fibromyalgia, with NDA preparation in progress. The posters will highlight other TNX-102 SL programs in clinical development, including Long COVID and Acute Stress Disorder.

Portfolio Pulse from Benzinga Newsdesk

May 22, 2024 | 12:18 pm

CRNX

Crinetics Pharmaceuticals shares are trading higher following the early release of ENDO 2024 late-breaking abstracts.

Portfolio Pulse from Benzinga Newsdesk

May 22, 2024 | 12:17 pm

AKTS

BNED

BRLS

CJET

CRKN

EDBL

EPRX

FLJ

LFST

LMFA

MBIO

MGOL

MGRX

RZLT

SINT

URBN

VRPX

VSAT

VSME

XYLO

Urban Outfitters shares surged by 6.7% in pre-market trading after reporting better-than-expected Q1 earnings and sales. Several other stocks, including MGO Global, Barnes & Noble Education, and Mustang Bio, also saw significant pre-market movements.

Portfolio Pulse from Avi Kapoor

May 22, 2024 | 12:16 pm

INDP

Indaptus Therapeutics has successfully advanced its Phase 1 trial for Decoy20, a novel immuno-oncology therapy targeting advanced solid tumors. The trial confirmed the 'Pulse-Prime' hypothesis and identified a tolerable single dose for multi-dosing, which will be presented at ASCO.

Portfolio Pulse from Benzinga Newsdesk

May 22, 2024 | 12:16 pm

BIVI

BioVie announced that its Phase 2a trial for bezisterim in Parkinson's Disease showed significant improvements in both non-motor and motor symptoms for treated patients, while placebo-treated patients worsened.

Portfolio Pulse from Benzinga Newsdesk

May 22, 2024 | 12:14 pm

XP

XP shares are trading lower after the company reported worse-than-expected Q1 EPS results.

Portfolio Pulse from Benzinga Newsdesk

May 22, 2024 | 12:14 pm

WSM

Williams-Sonoma shares are trading higher after the company reported Q1 financial results.

Portfolio Pulse from Benzinga Newsdesk

May 22, 2024 | 12:13 pm

ALZN

Alzamend Neuro, Inc. (NASDAQ:ALZN) has been granted an extension by the Nasdaq Hearings Panel to continue its listing on the Nasdaq Capital Market. The company must demonstrate compliance with the stockholder equity requirement of at least $2.5 million by September 23, 2024.

Portfolio Pulse from Benzinga Newsdesk

May 22, 2024 | 12:09 pm